Novartis India Ltd. - Research Center
500672 NOVARTIND Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 335.07 | 378.74 | 399.87 | 381.35 | 438.25 |
| Expenses | |||||
| Material consumed | 199.84 | 201.69 | 178.13 | 146.62 | 182.32 |
| Manufacturing expenses | 0.18 | 0.35 | 0.53 | 0.53 | 1.27 |
| Personnel expenses | 22.96 | 35.64 | 101.89 | 108.51 | 113.87 |
| Selling expenses | 1.94 | 6.10 | 7.46 | 9.80 | 13.75 |
| Adminstrative expenses | 44.89 | 69.88 | 84.75 | 89.10 | 115.01 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 269.81 | 313.66 | 372.76 | 354.56 | 426.22 |
| Operating profit | 65.26 | 65.08 | 27.11 | 26.79 | 12.03 |
| Other recurring income | 61.68 | 58.11 | 33.19 | 33.09 | 36.14 |
| Adjusted PBDIT | 126.94 | 123.19 | 60.30 | 59.88 | 48.17 |
| Financial expenses | 1.49 | 1.75 | 4.83 | 7.68 | 6.39 |
| Depreciation | 2.61 | 6.06 | 9.65 | 12.16 | 13.14 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 122.84 | 115.38 | 45.82 | 40.04 | 28.64 |
| Tax charges | 37.65 | 12.02 | -0.10 | 19.14 | 18.56 |
| Adjusted PAT | 85.19 | 103.36 | 45.92 | 20.90 | 10.08 |
| Non recurring items | 1.21 | 3.11 | -41.45 | -6.09 | -19.73 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 86.40 | 106.47 | 4.47 | 14.81 | -9.65 |
| Earnigs before appropriation | 846.12 | 784.41 | 702.63 | 722.85 | 737.81 |
| Equity dividend | 117.28 | 24.69 | 24.69 | 24.69 | 19.61 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | 5.08 |
| Retained earnings | 728.84 | 759.72 | 677.94 | 698.16 | 713.12 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis